NYSE:WATWaters Stock Price, Forecast & News

Waters' stock was trading at $184.10 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, WAT stock has increased by 8.5% and is now trading at $199.67. View which stocks have been most impacted by Coronavirus.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Waters in the last year. There are currently 6 sell ratings and 4 hold ratings for the stock, resulting in a consensus recommendation of "Sell." View analyst ratings for Waters.

Waters is scheduled to release its next quarterly earnings announcement on Tuesday, August 4th 2020. View our earnings forecast for Waters.

Waters Co. (NYSE:WAT) released its quarterly earnings results on Tuesday, April, 28th. The medical instruments supplier reported $1.15 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $1.39 by $0.24. The medical instruments supplier earned $464.94 million during the quarter, compared to analysts' expectations of $480.07 million. Waters had a return on equity of 1,937.83% and a net margin of 22.77%. The firm's revenue was down 9.5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.60 EPS. View Waters' earnings history.

10 equities research analysts have issued 12-month target prices for Waters' shares. Their forecasts range from $145.00 to $212.00. On average, they anticipate Waters' share price to reach $176.38 in the next twelve months. This suggests that the stock has a possible downside of 11.7%. View analysts' price targets for Waters.

News articles about WAT stock have trended negative this week, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Waters earned a media sentiment score of -2.8 on InfoTrie's scale. They also gave news articles about the medical instruments supplier a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutWaters.

Some companies that are related to Waters include Thermo Fisher Scientific (TMO), Illumina (ILMN), Agilent Technologies (A), Mettler-Toledo International (MTD), Bio-Rad Laboratories (BIO), PerkinElmer (PKI), BIO-TECHNE (TECH), Charles River Laboratories Intl. (CRL), Bruker (BRKR), Luminex (LMNX), Pacific Biosciences of California (PACB), Fluidigm (FLDM), Harvard Bioscience (HBIO), aTyr Pharma (LIFE) and BG Medicine (BGMD). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Waters investors own include Thermo Fisher Scientific (TMO), Honeywell International (HON), Home Depot (HD), CVS Health (CVS), Raytheon Technologies (RTX), Alibaba Group (BABA), Verizon Communications (VZ), Cisco Systems (CSCO), Walmart (WMT) and CSX (CSX).

Waters trades on the New York Stock Exchange (NYSE) under the ticker symbol "WAT."

Waters' stock is owned by a number of retail and institutional investors. Top institutional investors include Massachusetts Financial Services Co. MA (9.33%), BlackRock Inc. (8.65%), Fundsmith LLP (7.68%), Bank of New York Mellon Corp (7.54%), State Street Corp (4.66%) and Baillie Gifford & Co. (3.81%). Company insiders that own Waters stock include Christopher A Kuebler, Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, Mark T Beaudouin, Michael C Harrington, Michael F Silveira, Michael J Berendt, Robert G Carson, Terrence P Kelly and Thomas P Salice. View institutional ownership trends for Waters.

WAT stock was sold by a variety of institutional investors in the last quarter, including Fundsmith LLP, Ontario Teachers Pension Plan Board, Janus Henderson Group PLC, Mackenzie Financial Corp, APG Asset Management N.V., Deutsche Bank AG, Pictet Asset Management Ltd., and Morgan Stanley. Company insiders that have sold Waters company stock in the last year include Edward Conard, Elizabeth B Rae, Francis Kim, Ian King, Joann A Reed, Keeley A Aleman, Laurie H MD Glimcher, and Mark T Beaudouin. View insider buying and selling activity for Waters.

WAT stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Schroder Investment Management Group, JPMorgan Chase & Co., Massachusetts Financial Services Co. MA, Gateway Investment Advisers LLC, Bank of New York Mellon Corp, Swiss National Bank, and Balyasny Asset Management LLC. View insider buying and selling activity for Waters.

Shares of WAT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of WAT stock can currently be purchased for approximately $199.67.

Waters has a market capitalization of $12.36 billion and generates $2.41 billion in revenue each year. The medical instruments supplier earns $592.20 million in net income (profit) each year or $8.99 on an earnings per share basis. Waters employs 7,500 workers across the globe.

The official website for Waters is www.waters.com.

Waters' mailing address is 34 MAPLE STREET, MILFORD MA, 01757. The medical instruments supplier can be reached via phone at 508-478-2000 or via email at [email protected]